6622 — Zhaoke Ophthalmology Cashflow Statement
0.000.00%
- HK$737.29m
- -HK$579.02m
- CNY18.75m
Annual cashflow statement for Zhaoke Ophthalmology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -122 | -727 | -2,130 | -407 | -384 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 21.1 | 623 | 1,856 | 40.5 | -46.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 29.2 | -19 | 2.91 | 0.646 | 58.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -55.2 | -103 | -245 | -331 | -324 |
Capital Expenditures | -18.6 | -135 | -79.4 | -239 | -95.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -86.4 | -821 | 763 | -86 | 19.5 |
Change in Net Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -105 | -955 | 684 | -325 | -75.8 |
Financing Cash Flow Items | -45.3 | -3.03 | -81 | -3.14 | -5.88 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 303 | 974 | 1,659 | 76.2 | 99.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 148 | -89.7 | 2,063 | -412 | -255 |